Following is a transcript of the video. I'm Peter Green. I'm the director of the Celiac Disease Center at Columbia University. Celiac disease is actually a disease of Caucasians. The genes that ...

The study data serves as the first symptomatic clinical proof of concept for KAN-101 and its potential as a disease-modifying treatment for celiac disease. KAN-101 induces antigen-specific immune ...